Related Experiment Video

Updated: Mar 26, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

905

The anti-apoptosis effect of MLAA-34 in leukemia and the β-catenin/T cell factor 4 protein pathway

Lu Qian1, Wanggang Zhang2, Pengyu Zhang2

  • 1Department of Clinical Hematology, Affiliated No. 2 Hospital, Xi'an Jiaotong University School of MedicineThe West Five Road, 157#, Xi'an 710004, Shaanxi, China; Department of Medicine, The Fourth Hospital of Xi'anNo. 21 Jiefang Road, Shaanxi 710004, China.

American Journal of Translational Research
|January 26, 2016
PubMed

Insights

The MLAA-34 gene demonstrates an anti-apoptotic effect in leukemia, potentially by influencing the beta-Catenin/TCF 4 pathway. This finding offers new insights into leukemia mechanisms and potential therapeutic targets.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Genetics

Background:

  • Leukemia remains a significant health challenge, necessitating research into novel genetic factors.
  • Understanding gene function in leukemia progression is crucial for developing targeted therapies.

Purpose of the Study:

  • To investigate the role of the MLAA-34 gene in leukemia.
  • To elucidate the underlying molecular mechanisms of MLAA-34's effect on leukemia cells.

Main Methods:

  • Construction of MLAA-34 RNA interference (RNAi) vector.
  • Utilized cell lines (293T, K562, HL60, U937) and NOD/SCID mice.
  • Assessed cell proliferation, apoptosis, and expression of beta-Catenin and TCF 4 via Western blotting and immunohistochemistry.

Main Results:

  • MLAA-34 gene significantly correlated with U937 cell proliferation.
  • siRNA-mediated MLAA-34 knockdown increased apoptosis rates in U937 cells.
  • Distinct differences in beta-Catenin and TCF 4 expression were observed between U937 and MLAA-34-silenced U937 cells.

Conclusions:

  • MLAA-34 gene exhibits an anti-apoptotic effect in leukemia.
  • The beta-Catenin/TCF 4 pathway is implicated in MLAA-34's mechanism of action in leukemia.
Keywords:
MLAA-34apoptosisleukemiaβ-Catenin/TCF 4 pathway

More Related Videos

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity07:09

Myeloid Innate Signaling Pathway Regulation by MALT1 Paracaspase Activity

Published on: January 7, 2019

8.1K
Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway07:15

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway

Published on: August 23, 2024

1.1K

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
9.2K
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
9.3K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.9K